GNH USA

Europe — EMA

Noxap (Nitric Oxide)

Nitric Oxide, the active ingredient in Noxap, is a pulmonary vasodilator presented as a gas for inhalation use. It is employed to manage pulmonary hypertension and related vascular conditions in adult patients.

Request sourcing

1
Pack/s

What is Nitric Oxide?

Nitric Oxide, the active ingredient in Noxap, is a pulmonary vasodilator presented as a gas for inhalation use. It is employed to manage pulmonary hypertension and related vascular conditions in adult patients. GNH USA supplies Noxap as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH USA supplies Noxap as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

What is Nitric Oxide used for?

Noxap acts on the pulmonary vascular pathway for treatment of severe pulmonary hypertension. - Pulmonary arterial hypertension (PAH): Reduces the vascular resistance and improves exercise capacity by dilating pulmonary arteries. - Acute respiratory distress  syndrome (ARDS): Provides selective pulmonary vasodilation that helps improve oxygen exchange during critical care t  . - Post‑            """"  . -  . -   . - "   "  " " " " 

What are the side effects of Nitric Oxide?

​     ...  ...  ... ...

What precautions apply to Nitric Oxide?

​ … … 

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Nitric Oxide
Route
Inhalation Use
Manufacturer
Air Products Nederland B.V.
Origin
EU

Related products